BioTuesdays

Author - Sydney Stewart

Organigram

AGP starts Organigram at buy; PT $4

Alliance Global Partners initiated coverage of Organigram Holdings (TSX:OGI) with a “buy” rating and price target of $4 (Canadian). The stock closed at $2.11 on July 6. “We view Organigram’s low-cost indoor [cannabis]...

iBio Inc.

AGP starts iBio at buy; PT $2.55

Alliance Global Partners launched coverage of iBio (NYSE American:IBIO) with a “buy” rating and price target of $2.55. The stock closed at $1.61 on June 25 but has traded as high as $2.69 on June 26. Shares of iBio will...

Brookline Logo

Brookline boosts life sciences equity research

Brookline Capital Markets added Sally Yanchus and Leah Rush Cann to its life sciences equity research team.  With the addition of Ms. Yanchus and Ms. Cann, Brookline now has three publishing life sciences analysts, as...

HCW starts Aprea Therapeutics at neutral; PT $30

H.C. Wainwright initiated coverage of Aprea Therapeutics (NASDAQ:APRE) with a “neutral” rating and $30 price target. The stock closed at $37.90 on June 19. “We see more downside risk heading into pivotal data,” writes...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.